nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.0504	0.198	CbGeAlD
Amisulpride—HTR7—vagus nerve—peripheral nervous system neoplasm	0.0276	0.109	CbGeAlD
Amisulpride—HTR7—cranial nerve—peripheral nervous system neoplasm	0.021	0.0827	CbGeAlD
Amisulpride—HTR7—pons—peripheral nervous system neoplasm	0.0208	0.0817	CbGeAlD
Amisulpride—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.0184	0.0724	CbGeAlD
Amisulpride—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.0172	0.0677	CbGeAlD
Amisulpride—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.0131	0.0516	CbGeAlD
Amisulpride—HTR2A—pons—peripheral nervous system neoplasm	0.013	0.051	CbGeAlD
Amisulpride—Sulpiride—BCHE—peripheral nervous system neoplasm	0.0116	1	CrCbGaD
Amisulpride—HTR7—nerve—peripheral nervous system neoplasm	0.0108	0.0424	CbGeAlD
Amisulpride—HTR7—ganglion—peripheral nervous system neoplasm	0.0107	0.0419	CbGeAlD
Amisulpride—DRD2—nerve—peripheral nervous system neoplasm	0.0102	0.0401	CbGeAlD
Amisulpride—DRD2—ganglion—peripheral nervous system neoplasm	0.0101	0.0396	CbGeAlD
Amisulpride—HTR2A—nerve—peripheral nervous system neoplasm	0.00673	0.0264	CbGeAlD
Amisulpride—HTR2A—ganglion—peripheral nervous system neoplasm	0.00664	0.0261	CbGeAlD
Amisulpride—HTR7—brainstem—peripheral nervous system neoplasm	0.00463	0.0182	CbGeAlD
Amisulpride—DRD2—brainstem—peripheral nervous system neoplasm	0.00438	0.0172	CbGeAlD
Amisulpride—HTR2A—brainstem—peripheral nervous system neoplasm	0.00289	0.0113	CbGeAlD
Amisulpride—HTR7—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.00258	0.0975	CbGpPWpGaD
Amisulpride—HTR7—cerebellum—peripheral nervous system neoplasm	0.00228	0.00897	CbGeAlD
Amisulpride—DRD3—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.0022	0.0829	CbGpPWpGaD
Amisulpride—DRD2—cerebellum—peripheral nervous system neoplasm	0.00216	0.00848	CbGeAlD
Amisulpride—HTR2A—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.00165	0.0624	CbGpPWpGaD
Amisulpride—Vaginal infection—Epirubicin—peripheral nervous system neoplasm	0.00156	0.0022	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00154	0.00218	CcSEcCtD
Amisulpride—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.00154	0.00218	CcSEcCtD
Amisulpride—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00154	0.00218	CcSEcCtD
Amisulpride—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00154	0.00218	CcSEcCtD
Amisulpride—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.00154	0.00217	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00153	0.00216	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00153	0.00216	CcSEcCtD
Amisulpride—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00153	0.00216	CcSEcCtD
Amisulpride—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00153	0.00216	CcSEcCtD
Amisulpride—Constipation—Topotecan—peripheral nervous system neoplasm	0.00153	0.00216	CcSEcCtD
Amisulpride—Ventricular tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00153	0.00216	CcSEcCtD
Amisulpride—Pulmonary embolism—Doxorubicin—peripheral nervous system neoplasm	0.00153	0.00216	CcSEcCtD
Amisulpride—Vaginal inflammation—Doxorubicin—peripheral nervous system neoplasm	0.00153	0.00216	CcSEcCtD
Amisulpride—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00152	0.00214	CcSEcCtD
Amisulpride—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00152	0.00214	CcSEcCtD
Amisulpride—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.00151	0.00214	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00151	0.00214	CcSEcCtD
Amisulpride—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00151	0.00213	CcSEcCtD
Amisulpride—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.0015	0.00212	CcSEcCtD
Amisulpride—Salivary hypersecretion—Doxorubicin—peripheral nervous system neoplasm	0.00148	0.00209	CcSEcCtD
Amisulpride—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00146	0.00207	CcSEcCtD
Amisulpride—Agitation—Vincristine—peripheral nervous system neoplasm	0.00146	0.00206	CcSEcCtD
Amisulpride—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.00146	0.00206	CcSEcCtD
Amisulpride—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00145	0.00205	CcSEcCtD
Amisulpride—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00145	0.00205	CcSEcCtD
Amisulpride—Vaginal infection—Doxorubicin—peripheral nervous system neoplasm	0.00144	0.00204	CcSEcCtD
Amisulpride—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00143	0.00202	CcSEcCtD
Amisulpride—HTR2A—cerebellum—peripheral nervous system neoplasm	0.00142	0.0056	CbGeAlD
Amisulpride—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00142	0.00201	CcSEcCtD
Amisulpride—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00142	0.00201	CcSEcCtD
Amisulpride—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00142	0.00201	CcSEcCtD
Amisulpride—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00141	0.002	CcSEcCtD
Amisulpride—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00141	0.00199	CcSEcCtD
Amisulpride—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00141	0.00199	CcSEcCtD
Amisulpride—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.0014	0.00198	CcSEcCtD
Amisulpride—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.0014	0.00198	CcSEcCtD
Amisulpride—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.0014	0.00198	CcSEcCtD
Amisulpride—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.0014	0.00198	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.00139	0.00197	CcSEcCtD
Amisulpride—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00139	0.00197	CcSEcCtD
Amisulpride—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00138	0.00194	CcSEcCtD
Amisulpride—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00137	0.00194	CcSEcCtD
Amisulpride—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.00137	0.00194	CcSEcCtD
Amisulpride—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00137	0.00194	CcSEcCtD
Amisulpride—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.00135	0.00191	CcSEcCtD
Amisulpride—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.00134	0.00189	CcSEcCtD
Amisulpride—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.00133	0.00189	CcSEcCtD
Amisulpride—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00132	0.00186	CcSEcCtD
Amisulpride—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00132	0.00186	CcSEcCtD
Amisulpride—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00131	0.00186	CcSEcCtD
Amisulpride—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00131	0.00185	CcSEcCtD
Amisulpride—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00131	0.00185	CcSEcCtD
Amisulpride—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00131	0.00185	CcSEcCtD
Amisulpride—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.0013	0.00184	CcSEcCtD
Amisulpride—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00129	0.00182	CcSEcCtD
Amisulpride—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00128	0.00181	CcSEcCtD
Amisulpride—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00127	0.0018	CcSEcCtD
Amisulpride—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00127	0.0018	CcSEcCtD
Amisulpride—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00127	0.0018	CcSEcCtD
Amisulpride—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00127	0.00179	CcSEcCtD
Amisulpride—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00126	0.00178	CcSEcCtD
Amisulpride—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00126	0.00178	CcSEcCtD
Amisulpride—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00126	0.00178	CcSEcCtD
Amisulpride—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00125	0.00177	CcSEcCtD
Amisulpride—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00125	0.00177	CcSEcCtD
Amisulpride—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00125	0.00177	CcSEcCtD
Amisulpride—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00125	0.00177	CcSEcCtD
Amisulpride—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00124	0.00175	CcSEcCtD
Amisulpride—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.00124	0.00175	CcSEcCtD
Amisulpride—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00122	0.00173	CcSEcCtD
Amisulpride—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00122	0.00172	CcSEcCtD
Amisulpride—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00122	0.00172	CcSEcCtD
Amisulpride—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00121	0.00172	CcSEcCtD
Amisulpride—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00121	0.00172	CcSEcCtD
Amisulpride—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00121	0.00171	CcSEcCtD
Amisulpride—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.0012	0.00169	CcSEcCtD
Amisulpride—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.0012	0.00169	CcSEcCtD
Amisulpride—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00119	0.00168	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00119	0.00168	CcSEcCtD
Amisulpride—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00119	0.00168	CcSEcCtD
Amisulpride—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00167	CcSEcCtD
Amisulpride—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00118	0.00167	CcSEcCtD
Amisulpride—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00117	0.00166	CcSEcCtD
Amisulpride—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00117	0.00166	CcSEcCtD
Amisulpride—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00117	0.00166	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00116	0.00164	CcSEcCtD
Amisulpride—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00116	0.00164	CcSEcCtD
Amisulpride—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00115	0.00163	CcSEcCtD
Amisulpride—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00115	0.00163	CcSEcCtD
Amisulpride—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00115	0.00162	CcSEcCtD
Amisulpride—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.00114	0.00161	CcSEcCtD
Amisulpride—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00114	0.00161	CcSEcCtD
Amisulpride—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00113	0.00159	CcSEcCtD
Amisulpride—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00113	0.00159	CcSEcCtD
Amisulpride—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00112	0.00159	CcSEcCtD
Amisulpride—Headache—Topotecan—peripheral nervous system neoplasm	0.00112	0.00158	CcSEcCtD
Amisulpride—HTR7—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—peripheral nervous system neoplasm	0.00112	0.0422	CbGpPWpGaD
Amisulpride—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00112	0.00158	CcSEcCtD
Amisulpride—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00112	0.00158	CcSEcCtD
Amisulpride—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00111	0.00157	CcSEcCtD
Amisulpride—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00111	0.00157	CcSEcCtD
Amisulpride—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00111	0.00157	CcSEcCtD
Amisulpride—Headache—Tretinoin—peripheral nervous system neoplasm	0.00111	0.00157	CcSEcCtD
Amisulpride—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00111	0.00157	CcSEcCtD
Amisulpride—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00111	0.00157	CcSEcCtD
Amisulpride—Constipation—Vincristine—peripheral nervous system neoplasm	0.00111	0.00157	CcSEcCtD
Amisulpride—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00111	0.00157	CcSEcCtD
Amisulpride—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.0011	0.00155	CcSEcCtD
Amisulpride—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.00109	0.00155	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00109	0.00154	CcSEcCtD
Amisulpride—DRD3—Nicotine Activity on Dopaminergic Neurons—TH—peripheral nervous system neoplasm	0.00108	0.0406	CbGpPWpGaD
Amisulpride—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00107	0.00151	CcSEcCtD
Amisulpride—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00107	0.00151	CcSEcCtD
Amisulpride—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00107	0.00151	CcSEcCtD
Amisulpride—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00106	0.0015	CcSEcCtD
Amisulpride—Nausea—Topotecan—peripheral nervous system neoplasm	0.00106	0.0015	CcSEcCtD
Amisulpride—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00106	0.0015	CcSEcCtD
Amisulpride—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00105	0.00149	CcSEcCtD
Amisulpride—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00105	0.00149	CcSEcCtD
Amisulpride—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00149	CcSEcCtD
Amisulpride—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00104	0.00147	CcSEcCtD
Amisulpride—Nausea—Melphalan—peripheral nervous system neoplasm	0.00104	0.00147	CcSEcCtD
Amisulpride—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00102	0.00145	CcSEcCtD
Amisulpride—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00102	0.00144	CcSEcCtD
Amisulpride—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00101	0.00143	CcSEcCtD
Amisulpride—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00143	CcSEcCtD
Amisulpride—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000992	0.0014	CcSEcCtD
Amisulpride—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00099	0.0014	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000989	0.0014	CcSEcCtD
Amisulpride—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000981	0.00139	CcSEcCtD
Amisulpride—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000967	0.00137	CcSEcCtD
Amisulpride—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000965	0.00136	CcSEcCtD
Amisulpride—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000954	0.00135	CcSEcCtD
Amisulpride—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000951	0.00134	CcSEcCtD
Amisulpride—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000941	0.00133	CcSEcCtD
Amisulpride—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000936	0.00132	CcSEcCtD
Amisulpride—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000933	0.00132	CcSEcCtD
Amisulpride—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000933	0.00132	CcSEcCtD
Amisulpride—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000929	0.00131	CcSEcCtD
Amisulpride—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000922	0.0013	CcSEcCtD
Amisulpride—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00092	0.0013	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000906	0.00128	CcSEcCtD
Amisulpride—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000905	0.00128	CcSEcCtD
Amisulpride—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000904	0.00128	CcSEcCtD
Amisulpride—Constipation—Etoposide—peripheral nervous system neoplasm	0.000897	0.00127	CcSEcCtD
Amisulpride—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000895	0.00127	CcSEcCtD
Amisulpride—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000889	0.00126	CcSEcCtD
Amisulpride—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000886	0.00125	CcSEcCtD
Amisulpride—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000871	0.00123	CcSEcCtD
Amisulpride—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000866	0.00122	CcSEcCtD
Amisulpride—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000863	0.00122	CcSEcCtD
Amisulpride—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000861	0.00122	CcSEcCtD
Amisulpride—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000861	0.00122	CcSEcCtD
Amisulpride—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000858	0.00121	CcSEcCtD
Amisulpride—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000857	0.00121	CcSEcCtD
Amisulpride—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000855	0.00121	CcSEcCtD
Amisulpride—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000844	0.00119	CcSEcCtD
Amisulpride—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000843	0.00119	CcSEcCtD
Amisulpride—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000842	0.00119	CcSEcCtD
Amisulpride—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000836	0.00118	CcSEcCtD
Amisulpride—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000834	0.00118	CcSEcCtD
Amisulpride—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00083	0.00117	CcSEcCtD
Amisulpride—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000824	0.00116	CcSEcCtD
Amisulpride—DRD2—Nicotine Activity on Dopaminergic Neurons—TH—peripheral nervous system neoplasm	0.000823	0.0311	CbGpPWpGaD
Amisulpride—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000822	0.00116	CcSEcCtD
Amisulpride—Headache—Vincristine—peripheral nervous system neoplasm	0.000812	0.00115	CcSEcCtD
Amisulpride—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000799	0.00113	CcSEcCtD
Amisulpride—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000796	0.00113	CcSEcCtD
Amisulpride—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000784	0.00111	CcSEcCtD
Amisulpride—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.00078	0.0011	CcSEcCtD
Amisulpride—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000773	0.00109	CcSEcCtD
Amisulpride—Nausea—Vincristine—peripheral nervous system neoplasm	0.000769	0.00109	CcSEcCtD
Amisulpride—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000768	0.00109	CcSEcCtD
Amisulpride—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000753	0.00106	CcSEcCtD
Amisulpride—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000751	0.00106	CcSEcCtD
Amisulpride—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000748	0.00106	CcSEcCtD
Amisulpride—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000742	0.00105	CcSEcCtD
Amisulpride—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000728	0.00103	CcSEcCtD
Amisulpride—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000725	0.00103	CcSEcCtD
Amisulpride—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000721	0.00102	CcSEcCtD
Amisulpride—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000718	0.00101	CcSEcCtD
Amisulpride—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000711	0.00101	CcSEcCtD
Amisulpride—Tension—Epirubicin—peripheral nervous system neoplasm	0.000707	0.001	CcSEcCtD
Amisulpride—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.0007	0.00099	CcSEcCtD
Amisulpride—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000695	0.000982	CcSEcCtD
Amisulpride—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000694	0.000981	CcSEcCtD
Amisulpride—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000693	0.00098	CcSEcCtD
Amisulpride—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000692	0.000978	CcSEcCtD
Amisulpride—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00068	0.000962	CcSEcCtD
Amisulpride—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000671	0.000949	CcSEcCtD
Amisulpride—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000667	0.000943	CcSEcCtD
Amisulpride—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000667	0.000943	CcSEcCtD
Amisulpride—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000662	0.000936	CcSEcCtD
Amisulpride—Headache—Etoposide—peripheral nervous system neoplasm	0.000657	0.000929	CcSEcCtD
Amisulpride—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000654	0.000925	CcSEcCtD
Amisulpride—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000648	0.000916	CcSEcCtD
Amisulpride—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000645	0.000912	CcSEcCtD
Amisulpride—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000641	0.000906	CcSEcCtD
Amisulpride—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000624	0.000883	CcSEcCtD
Amisulpride—Nausea—Etoposide—peripheral nervous system neoplasm	0.000623	0.000881	CcSEcCtD
Amisulpride—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000622	0.00088	CcSEcCtD
Amisulpride—HTR2A—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000617	0.0233	CbGpPWpGaD
Amisulpride—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000613	0.000866	CcSEcCtD
Amisulpride—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000611	0.000864	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000609	0.000861	CcSEcCtD
Amisulpride—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.0006	0.000848	CcSEcCtD
Amisulpride—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000597	0.000844	CcSEcCtD
Amisulpride—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000578	0.000817	CcSEcCtD
Amisulpride—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000577	0.000815	CcSEcCtD
Amisulpride—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000576	0.000814	CcSEcCtD
Amisulpride—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000571	0.000808	CcSEcCtD
Amisulpride—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000569	0.000804	CcSEcCtD
Amisulpride—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000566	0.0008	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000564	0.000797	CcSEcCtD
Amisulpride—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000555	0.000785	CcSEcCtD
Amisulpride—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00055	0.000777	CcSEcCtD
Amisulpride—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000534	0.000754	CcSEcCtD
Amisulpride—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000532	0.000752	CcSEcCtD
Amisulpride—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000529	0.000747	CcSEcCtD
Amisulpride—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000526	0.000744	CcSEcCtD
Amisulpride—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000523	0.000739	CcSEcCtD
Amisulpride—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000518	0.000732	CcSEcCtD
Amisulpride—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000509	0.000719	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000508	0.000718	CcSEcCtD
Amisulpride—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000507	0.000717	CcSEcCtD
Amisulpride—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000503	0.000711	CcSEcCtD
Amisulpride—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000492	0.000696	CcSEcCtD
Amisulpride—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000484	0.000684	CcSEcCtD
Amisulpride—HTR7—G alpha (s) signalling events—VIP—peripheral nervous system neoplasm	0.000481	0.0182	CbGpPWpGaD
Amisulpride—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000481	0.00068	CcSEcCtD
Amisulpride—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000479	0.000677	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00047	0.000664	CcSEcCtD
Amisulpride—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000469	0.000663	CcSEcCtD
Amisulpride—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000467	0.000661	CcSEcCtD
Amisulpride—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000465	0.000658	CcSEcCtD
Amisulpride—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000465	0.000657	CcSEcCtD
Amisulpride—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000629	CcSEcCtD
Amisulpride—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000433	0.000613	CcSEcCtD
Amisulpride—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000432	0.000611	CcSEcCtD
Amisulpride—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00043	0.000608	CcSEcCtD
Amisulpride—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000422	0.000597	CcSEcCtD
Amisulpride—HTR2B—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.000418	0.0158	CbGpPWpGaD
Amisulpride—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000416	0.000588	CcSEcCtD
Amisulpride—HTR2B—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—NRAS—peripheral nervous system neoplasm	0.00041	0.0155	CbGpPWpGaD
Amisulpride—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000569	CcSEcCtD
Amisulpride—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000401	0.000567	CcSEcCtD
Amisulpride—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.000552	CcSEcCtD
Amisulpride—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000389	0.00055	CcSEcCtD
Amisulpride—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000385	0.000544	CcSEcCtD
Amisulpride—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000374	0.000529	CcSEcCtD
Amisulpride—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.000373	0.0141	CbGpPWpGaD
Amisulpride—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000526	CcSEcCtD
Amisulpride—Headache—Epirubicin—peripheral nervous system neoplasm	0.000368	0.000521	CcSEcCtD
Amisulpride—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00036	0.000509	CcSEcCtD
Amisulpride—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000349	0.000494	CcSEcCtD
Amisulpride—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.000489	CcSEcCtD
Amisulpride—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000341	0.000482	CcSEcCtD
Amisulpride—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.000457	CcSEcCtD
Amisulpride—HTR7—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000303	0.0114	CbGpPWpGaD
Amisulpride—HTR2B—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HRAS—peripheral nervous system neoplasm	0.0003	0.0113	CbGpPWpGaD
Amisulpride—HTR2A—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.000293	0.011	CbGpPWpGaD
Amisulpride—HTR2A—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—NRAS—peripheral nervous system neoplasm	0.000287	0.0108	CbGpPWpGaD
Amisulpride—HTR2B—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000277	0.0104	CbGpPWpGaD
Amisulpride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.000262	0.00988	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000257	0.00971	CbGpPWpGaD
Amisulpride—HTR7—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.000249	0.00941	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00023	0.0087	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000221	0.00834	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000211	0.00795	CbGpPWpGaD
Amisulpride—HTR2A—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HRAS—peripheral nervous system neoplasm	0.00021	0.00793	CbGpPWpGaD
Amisulpride—HTR7—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000208	0.00784	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000202	0.00762	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000197	0.00743	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000196	0.0074	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000194	0.00731	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000188	0.00709	CbGpPWpGaD
Amisulpride—HTR2B—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.000188	0.00708	CbGpPWpGaD
Amisulpride—HTR7—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000185	0.00697	CbGpPWpGaD
Amisulpride—HTR2A—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000178	0.00671	CbGpPWpGaD
Amisulpride—DRD3—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000176	0.00666	CbGpPWpGaD
Amisulpride—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.000168	0.00633	CbGpPWpGaD
Amisulpride—HTR2A—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000163	0.00614	CbGpPWpGaD
Amisulpride—DRD3—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000157	0.00593	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00015	0.00566	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000148	0.00557	CbGpPWpGaD
Amisulpride—DRD3—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.000145	0.00549	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000144	0.00543	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000141	0.00534	CbGpPWpGaD
Amisulpride—HTR7—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000136	0.00513	CbGpPWpGaD
Amisulpride—DRD2—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000135	0.0051	CbGpPWpGaD
Amisulpride—HTR2A—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000133	0.00501	CbGpPWpGaD
Amisulpride—HTR2A—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.000131	0.00496	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00013	0.00492	CbGpPWpGaD
Amisulpride—DRD3—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.000127	0.0048	CbGpPWpGaD
Amisulpride—HTR2B—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000124	0.00469	CbGpPWpGaD
Amisulpride—DRD2—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.00012	0.00454	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000119	0.00449	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000118	0.00446	CbGpPWpGaD
Amisulpride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.000118	0.00444	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000116	0.00436	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000113	0.00428	CbGpPWpGaD
Amisulpride—DRD2—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.000111	0.0042	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000111	0.00418	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000108	0.00408	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000104	0.00391	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000104	0.00391	CbGpPWpGaD
Amisulpride—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000102	0.00385	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000101	0.0038	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	9.87e-05	0.00373	CbGpPWpGaD
Amisulpride—DRD2—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	9.73e-05	0.00367	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CD55—peripheral nervous system neoplasm	9.64e-05	0.00364	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	9.46e-05	0.00357	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	9.05e-05	0.00342	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	9.02e-05	0.0034	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—VIP—peripheral nervous system neoplasm	8.96e-05	0.00338	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	8.85e-05	0.00334	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	8.8e-05	0.00332	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	8.7e-05	0.00329	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	8.47e-05	0.0032	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	8.39e-05	0.00317	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	8.34e-05	0.00315	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	8.27e-05	0.00312	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	8.27e-05	0.00312	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—VIP—peripheral nervous system neoplasm	8.19e-05	0.00309	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	7.7e-05	0.00291	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	7.69e-05	0.0029	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—VIP—peripheral nervous system neoplasm	7.62e-05	0.00288	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	7.57e-05	0.00286	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	7.56e-05	0.00285	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	7.38e-05	0.00278	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	7.26e-05	0.00274	CbGpPWpGaD
Amisulpride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	7.14e-05	0.0027	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	7.03e-05	0.00265	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.99e-05	0.00264	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	6.74e-05	0.00254	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CD55—peripheral nervous system neoplasm	6.7e-05	0.00253	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	6.63e-05	0.0025	CbGpPWpGaD
Amisulpride—HTR2A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	6.62e-05	0.0025	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	6.42e-05	0.00242	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.38e-05	0.00241	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	6.32e-05	0.00239	CbGpPWpGaD
Amisulpride—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	6.13e-05	0.00231	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CD55—peripheral nervous system neoplasm	6.12e-05	0.00231	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—NTS—peripheral nervous system neoplasm	5.94e-05	0.00224	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	5.89e-05	0.00222	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	5.85e-05	0.00221	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	5.83e-05	0.0022	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	5.8e-05	0.00219	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	5.74e-05	0.00217	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CD55—peripheral nervous system neoplasm	5.69e-05	0.00215	CbGpPWpGaD
Amisulpride—HTR7—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	5.42e-05	0.00204	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	5.38e-05	0.00203	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	5.35e-05	0.00202	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.31e-05	0.00201	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	5.29e-05	0.002	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.29e-05	0.002	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	5.12e-05	0.00193	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	4.98e-05	0.00188	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.89e-05	0.00184	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.86e-05	0.00183	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.84e-05	0.00183	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.68e-05	0.00177	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.65e-05	0.00175	CbGpPWpGaD
Amisulpride—DRD3—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	4.61e-05	0.00174	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NTS—peripheral nervous system neoplasm	4.55e-05	0.00172	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.52e-05	0.00171	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.5e-05	0.0017	CbGpPWpGaD
Amisulpride—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	4.49e-05	0.00169	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NTS—peripheral nervous system neoplasm	4.47e-05	0.00169	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.46e-05	0.00169	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CD55—peripheral nervous system neoplasm	4.36e-05	0.00165	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.35e-05	0.00164	CbGpPWpGaD
Amisulpride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	4.3e-05	0.00162	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CD55—peripheral nervous system neoplasm	4.29e-05	0.00162	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.25e-05	0.0016	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.15e-05	0.00157	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	3.95e-05	0.00149	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	3.81e-05	0.00144	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	3.75e-05	0.00141	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.67e-05	0.00139	CbGpPWpGaD
Amisulpride—DRD2—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	3.52e-05	0.00133	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	3.46e-05	0.00131	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—VIP—peripheral nervous system neoplasm	3.44e-05	0.0013	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	3.4e-05	0.00128	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	3.39e-05	0.00128	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.35e-05	0.00127	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	3.33e-05	0.00126	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	3.28e-05	0.00124	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.23e-05	0.00122	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	3.18e-05	0.0012	CbGpPWpGaD
Amisulpride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	3.14e-05	0.00119	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.14e-05	0.00119	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	3.13e-05	0.00118	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.12e-05	0.00118	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	3.02e-05	0.00114	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.99e-05	0.00113	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.97e-05	0.00112	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.95e-05	0.00111	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.87e-05	0.00108	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.75e-05	0.00104	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.74e-05	0.00104	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.73e-05	0.00103	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.67e-05	0.00101	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.54e-05	0.00096	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.51e-05	0.000947	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.39e-05	0.000901	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.35e-05	0.000887	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.33e-05	0.000881	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.1e-05	0.000793	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.07e-05	0.00078	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.04e-05	0.000771	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.01e-05	0.000759	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.95e-05	0.000735	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.94e-05	0.000733	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.92e-05	0.000723	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.91e-05	0.00072	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.79e-05	0.000674	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.77e-05	0.00067	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.76e-05	0.000663	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.74e-05	0.000658	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.65e-05	0.000623	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.62e-05	0.000612	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.51e-05	0.000569	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.42e-05	0.000536	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.38e-05	0.000521	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.38e-05	0.00052	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.37e-05	0.000517	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.3e-05	0.00049	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.28e-05	0.000484	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.26e-05	0.000477	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.26e-05	0.000476	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.25e-05	0.000473	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.25e-05	0.000472	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.24e-05	0.000469	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.24e-05	0.000469	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.22e-05	0.000461	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.21e-05	0.000456	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.17e-05	0.000443	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.16e-05	0.000439	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.15e-05	0.000433	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.15e-05	0.000433	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.07e-05	0.000403	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.07e-05	0.000403	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.05e-05	0.000396	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.81e-06	0.00037	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.76e-06	0.000369	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.75e-06	0.000368	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.65e-06	0.000364	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.24e-06	0.000349	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.09e-06	0.000343	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.08e-06	0.000343	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.99e-06	0.000339	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.9e-06	0.000336	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.84e-06	0.000334	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.77e-06	0.000331	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.76e-06	0.000331	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.39e-06	0.000317	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.16e-06	0.000308	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.03e-06	0.000303	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.02e-06	0.000303	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.67e-06	0.000289	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.46e-06	0.000282	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.46e-06	0.000282	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.41e-06	0.00028	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.34e-06	0.000277	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.13e-06	0.000269	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.95e-06	0.000262	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.84e-06	0.000258	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.77e-06	0.000256	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.3e-06	0.000238	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.71e-06	0.000216	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.62e-06	0.000212	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.46e-06	0.000206	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.37e-06	0.000203	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.82e-06	0.000182	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.74e-06	0.000179	CbGpPWpGaD
